Browse > Article
http://dx.doi.org/10.5010/JPB.2005.32.4.233

Recent Studies on the Edible Plant Vaccine for Prophylactic Medicine against Microorganism-Mediated Diseases  

Hahn Bum-Soo (Plant Metabolic Engineering Team, National Institute of Agricultural Biotechnology)
Jeong Young-Jae (Plant Metabolic Engineering Team, National Institute of Agricultural Biotechnology)
Roh Kyung-Hee (Plant Metabolic Engineering Team, National Institute of Agricultural Biotechnology)
Park Jong-Sug (Plant Metabolic Engineering Team, National Institute of Agricultural Biotechnology)
Cho Kang-Jin (Plant Metabolic Engineering Team, National Institute of Agricultural Biotechnology)
Kim Yong-Hwan (Plant Metabolic Engineering Team, National Institute of Agricultural Biotechnology)
Kim Jong-Bum (Plant Metabolic Engineering Team, National Institute of Agricultural Biotechnology)
Publication Information
Journal of Plant Biotechnology / v.32, no.4, 2005 , pp. 233-241 More about this Journal
Abstract
Plants have considerable advantages for the production of antigenic proteins because they provide an inexpensive source of protein and an easy administration of vaccine. Since a publication describing edible plant vaccine of HBsAg in 1992, a number of laboratories around the world have studied the use of plants as the bioreactor to produce antigenic proteins of human or animal pathogens. Over the last ten years, these works have been mainly focused on three major strategies for the production of antigenic proteins in plants: stable genetic transformation of either the nuclear or plastid genome, or transient expression in plants using viral vectors. As many antigenic proteins have been expressed in tobacco, also several laboratories have succeeded to express genes encoding antigenic proteins in other crop plants: potato, tomato, maize, carrot, soybean and spinach. At present many works for the production of edible plant vaccine against bacteria-mediated diseases have mostly performed the studies of enterotoxins and adhesion proteins. Also the development of new-type antigens (pili, flagella, surface protein, other enterotoxin and exotoxin etc.) is required for various targets and more efficacy to immunize against microorganism pathogens. Many works mostly studied in experimental animals had good results, and phase I clinical trial of LTB clearly indicated its immunogenic ability. On the other hand, edible plant vaccines have still problems remained to be solved. In addition to the accumulation of sufficient antigen in plants, human health, environment and agriculture regulation should be proven. Also oral tolerance, the physiological response to food antigens and commensal flora is the induction of a state of specific immunological unresponsiveness, needs to be addressed before plant-derived vaccine becomes a therapeutic option.
Keywords
Edible plant vaccine; genetically modified crop; microorganism-mediated diseases; mucosal immune system;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Walmsley AM, Kirk DD, Mason HS (2003) Passive immunization of mice pups through oral immunization of dams with a plant-derived vaccine. Immunol Lett 86: 71-76   DOI   ScienceOn
2 Wang XG, Zhang GH, Liu CX, Zhang YH, Xiao CZ, Fang RX (2001) Purified cholera toxin B subunit from transgenic tobacco plants possesses authentic antigenicity. Biotechnol Bioeng 72: 490-494   DOI   ScienceOn
3 Webster DE, Thomas MC, Strugnell RA, Dry IB, Wesselingh SL (2002) Appetising solutions: an edible vaccine for measles. Med J Aust 176: 434-437
4 WHO (2000). Supplementary information on vaccine safety. Genova. World Health Organization $(WHO/v{\epsilon}B/00.36)$
5 Yates WDG (1982) A review of infectious bovine rhinotracheitis, shipping. fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can J Comp Med 46: 225-263
6 Yu J, Langridge WH (2001) A plant-based multicomponent vaccine protects mice from enteric diseases. Nat Biotechnol 19: 548-552   DOI   ScienceOn
7 Tacket CO, Pasetti MF. Edelman R, Howard JA, Streatfield S (2004) Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 22: 4385-4389   DOI   ScienceOn
8 Toth RL, Chapman S, Carr F, Santa Cruz S (2001) A novel strategy for the expression of foreign genes from plant virus vectors. FEBS Lett 489: 215-219   DOI   ScienceOn
9 Tregoning JS, Nixon P, Kuroda H, Svab Z, Clare S, Bowe F, Fairweather N, Ytterberg J, van Wijk KJ, Dougan G, Maliga P (2003) Expression of tetanus toxin Fragment C in tobacco chloroplasts. Nucleic Acids Res 31: 1174-1179   DOI   ScienceOn
10 Tregoning J, Maliga P, Dougan G, Nixon PJ (2004) New advances in the production of edible plant vaccines: chloroplast expression of a tetanus vaccine antigen, TetC. Phytochemistry 65: 989-994   DOI   ScienceOn
11 Van den Broeck W, Bouchaut H, Cox E, Goddeeris BM (2002) F4 receptor-independent priming of the systemic immune system of pigs by low oral doses of F4 fimbriae Vet Immunol Immunopathol 85: 171-178   DOI   ScienceOn
12 Van der Velden AW, Thomas AA (1999) The role of the 5’ untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol 31: 87-106   DOI   ScienceOn
13 Walmsley AM, Alvarez ML, Jin Y, Kirk DD, Lee SM, Pinkhasov J, Rigano MM, Arntzen CJ, Mason HS (2003) Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato. Plant Cell Rep 21: 1020-1026   DOI
14 Stevceva L, Ferrari MG (2005). Mucosal adjuvants. Curr Pharm Des 11: 801-811   DOI   ScienceOn
15 Tacket CO, Mason HS, Losonsky G, Clements JD , Levine MM, Arntzen CJ (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 4: 607-609   DOI   ScienceOn
16 Medaglini D, Pozzi G, King TP, Fischetti VA (1995) Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci USA 92: 6868-6872   DOI
17 Metcalfe N (2002) A short history of biological warfare. Med Confl Surviv 18: 271-282   DOI   ScienceOn
18 Pisarev AV, Shirokikh NE, Hellen CU (2005) Translation initiation by factor-independent binding of eukaryotic ribosomes to internal ribosomal entry sites. C R Biol 328: 589-605   DOI   ScienceOn
19 Muhlbauer SK, Koop HU (2005) External control of transgene expression in tobacco plastids using the bacterial lac repressor. Plant J 43: 941-946   DOI   ScienceOn
20 Richter LJ, Thanavala Y, Arntzen CJ, Mason HS (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 18: 1167-1171   DOI   ScienceOn
21 Robinson K, Chamberlain LM, Schofield KM, Wells JM, Le Page RW (1997) Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol 15: 653-657   DOI   ScienceOn
22 Ruf S, Hermann M, Berger IJ, Carrer H, Bock R (2001) Stable genetic transformation of tomato plastids and expression of a foreign protein in fruit. Nat Biotechnol 19: 870-875   DOI   ScienceOn
23 Schmitt CK, Meysick KC, O’Brien AD (1999) Bacterial toxins: friends or foes? Emerg Infect Dis 5: 224-234   DOI   ScienceOn
24 Skarjinskaia M, Svab Z, Maliga P (2003) Plastid transformation in Lesquerella fendleri, an oilseed Brassicacea. Transgenic Res 12: 115-122   DOI   ScienceOn
25 Smith ML, Richter L, Arntzen CJ, Shuler ML, Mason HS (2003) Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies. Vaccine 21: 4011-4021   DOI   ScienceOn
26 Lauterslager TG, Florack DE, van der Wal TJ, Molthoff JW, Langeveld JP, Bosch D, Boersma WJ, Hilgers LA (2001) Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine 19: 2749-2755   DOI   ScienceOn
27 Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA 93: 5335-5340   DOI
28 Lee RW, Strommer J, Hodgins D, Shewen PE, Niu Y, Lo RY (2001) Towards development of an edible vaccine against bovine pneumonic pasteurellosis using transgenic white clover expressing a Mannheimia haemolytica A1 leukotoxin 50 fusion protein. Infect Immun 69: 5786-5793   DOI
29 Lee YS, Hwang CH (2002) Development of transgenic carrot oral vaccine to project against diarrhea of piglets. Kor J Plant Biotechnol 29: 287-293   DOI   ScienceOn
30 McBride KE, Schaaf DJ, Daley M, Stalker DM (1994) Controlled expression of plastid transgenes in plants based on a nuclear DNA-encoded and plastid-targeted T7 RNA polymerase. Proc Natl Acad Sci USA 91: 7301-7305   DOI
31 Mason HS, Haq TA, Clements JD, Arntzen CJ (1998) Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16: 1336-1343   DOI   ScienceOn
32 Mason HS, Lam DM, Arntzen CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA 89: 11745-11749   DOI   ScienceOn
33 May GD, Afza R, Mason HS, Wiecko A, Novak FJ, Arntzen CJ (2004) Generation of transgenic banana (Musa acuminata) plants via Agrobacterium-mediated transformation. Bio/Technol 13: 486-492   DOI
34 Jani D, Singh NK, Bhattacharya S, Meena LS, Singh Y, Upadhyay SN, Sharma AK, Tyagi AK (2004) Studies on the immunogenic potential of plant-expressed cholera toxin B subunit. Plant Cell Rep 22: 471-477   DOI
35 Kang TJ, Han SC, Jang MO, Kang KH, Jang YS, Yang MS (2004) Enhanced expression of B-subunit of Escherichia coif heat-labile enterotoxin in tobacco by optimization of coding sequence. Appl Biochem Biotechnol 117: 175-187   DOI   ScienceOn
36 Jin LZ, Zhao X (2000) Intestinal receptors for adhesive fimbriae of enterotoxigenic Escherichia coli (ETEC) K88 in swinea review. Appl Microbiol Biotechnol 54: 311-318   DOI
37 Kang TJ, Han SC, Kim MV, Kim YS, Yang MS (2004) Expression of non-toxic mutant of Escherichia coli heat-labile enterotoxin in tobacco chloroplasts. Protein Expr Purif 38: 123-128   DOI   ScienceOn
38 Kang TJ, Loc NH, Jang MO, Jang YS, Kim YS, Seo JE, Yang MS (2003) Expression of the B subunit of E. coli heat-labile enterotoxin in the chloroplasts of plants and its characterization. Transgenic Res 12: 683-691   DOI   ScienceOn
39 Kapusta J, Modelska A, Figlerowicz M, Pniewski T, Letellier M, Lisowa O, Yusibov V, Koprowski H, Plucienniczak A, Legocki AB (1999) A plant-derived edible vaccine against hepatitis B virus. FASEB J 13: 1796-1769   DOI
40 Kapusta J, Modelska A, Pniewski T, Figlerowicz M, Jankowski K, Lisowa O, Plucienniczak A, Koprowski H, Legocki AB (2001) Oral immunization of human with transgenic lettuce expressing hepatitis B surface antigen. Adv Exp Med Biol 495: 299-303   DOI
41 Karasev AV, A. B., Koprowski H (2003) Production of the Bacillus antracis Protective antigen fragments in plants. Expert Rev Vaccines American society for Microbiology biodefense Research Meeting, Baltimore, MD, USA: abstract 73
42 Kim TG, Langridge WH (2003) Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic potato. Plant Cell Rep 21: 884-890
43 Griffin D (1997) Economic impact associated with respiratory disease on beef cattle, p. 367-377. In J. Vestweber and G. St. Jean (ed.), Veterinary clinics of North America: food animal practice. W. B. Saunders Co., Philadelphia, Pa.
44 Daniell H, Lee SB, Panchal T, Wiebe PO (2001) Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J Mol Biol 311: 1001-1009   DOI   ScienceOn
45 Dufourmantel N, Pelissier B, Garcon F, Peltier G, Ferullo JM, Tissot G (2004) Generation of fertile transplastomic soybean. Plant Mol Biol 55: 479-489   DOI   ScienceOn
46 Friedlander AM (1999) Clinical aspects, diagnosis and treatment of anthrax J Appl Microbiol 87: 303   DOI
47 Hahn BS, Park JS, Kim HK, Ha SH, Cho KJ, Kim YH, Kim JB (2004) Recent studies of edible plant vaccine for prophylactic medicine against virus-mediated diseases. Kor J Plant Biotechnol 31: 151-161   과학기술학회마을   DOI   ScienceOn
48 Haq TA, Mason HS, Clements JD, Arntzen CJ (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268: 714-716   DOI   ScienceOn
49 Hein MB, Yeo TC, Wang F, Sturtevant A (1996) Expression of cholera toxin subunits in plants. Ann N V Acad Sci 792: 50-56   DOI
50 Huang Z, Dry I, Webster D, Strugnell R, Wesselingh S (2001) Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice. Vaccine 19: 2163-2171   DOI   ScienceOn
51 Jani D, Meena LS, Rizwan-ul-Haq QM, Singh V, Sharma AK, Tyagi AK (2002) Expression of cholera toxin B subunit in transgenic tomato plants. Transgenic Res 11: 447-454   DOI   ScienceOn
52 Biemelt S, Sonnewald U, Galmbacher P, Willmitzer L, Muller M (2003) Production of human papillomavirus type 16 virus-like particles in transgenic plants. J Virol 77: 9211-9220   DOI
53 Arakawa T, Chong DK, Langridge WH (1998) Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat Biotechnol 16: 292-297   DOI   ScienceOn
54 Arakawa T, Chong DK, Merritt JL, Langridge WH (1997) Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Res 6: 403-413   DOI   ScienceOn
55 Aziz MA, Singh S, Anand Kumar P, Bhatnagar R (2002) Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax. Biochem Biophys Res Commun 299: 345-351   DOI   ScienceOn
56 Brachman PS, Gold H, Plotkin SA, Fekety FR, Werrin M, Ingraham NR (1962) Field evaluation of human anthrax vaccine, Am J Public Health 52: 632-645   DOI
57 Chen YJ, Chen WS, Wu TY (2005) Development of a bi-cistronic baculovirus expression vector by the Rhopalosiphum padi virus 5’ internal ribosome entry site. Biochem Biophys Res Commun 335: 616-623   DOI   ScienceOn
58 Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K (2002) A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (L.T) and cholera toxin (CT). Transgenic Res 11: 479-493   DOI   ScienceOn
59 Confer AW, Clinkenbeard KD, Murphy GL (1995) Pathogenesis and virulence of Pasteurella haemolytica in cattle: an analysis of currentknowledge and future approaches, p. 51-62. In W. Donachie, F. A. Lainson, and J. C. Hodgson (ed.), Haemophilus, Actinobacillus, and Pasteurella. Plenum Press, New York, N.V.
60 Cox E, Van der Stede V, Verdonck F, Snoeck V, Van den Broeck W, Goddeeris B (2002) Oral immunisation of pigs with fimbrial antigens of enterotoxigenic E. coli: an interesting model to study mucosal immune mechanisms. Vet Immunol Immunopathol 87: 287-290   DOI   ScienceOn
61 Brandtzaeg P (1996) History of oral tolerance and mucosal immunity. Ann N Y Acad Sci 778: 1-27   DOI   ScienceOn
62 Ackermann MR, Brogden KA (2000) Response of the ruminant respiratory tract to Mannheimia (Pasteurella) haemolytica. Microbes Infect 2: 1079-1088   DOI   ScienceOn